ACH

Business Context and Reporting Period

This summary covers the Form 10-Q filed by Owens & Minor, Inc. (Note: The input metadata referenced "Accendra Health Inc," but the filing text explicitly identifies the registrant as Owens & Minor, Inc.) for the quarterly period ended September 30, 2007. The company operates as a distributor of medical and surgical supplies, including a direct-to-consumer (DTC) segment. The reporting period includes the integration of the McKesson Acute-Care business acquired in September 2006.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 27.9% in Q3 and 30.2% year-to-date (YTD) compared to 2006. Approximately 70% of this growth is attributed to the acquired McKesson Acute-Care business, with the remainder driven by sales to existing customers and net new business.
• Profitability: Operating earnings improved significantly, rising 59.8% in Q3 and 17.5% YTD. This improvement was aided by the absence of a $11.4 million debt extinguishment charge recorded in Q2 2006 and a $4.5 million allowance for doubtful accounts charge in Q3 2006 related to the DTC business.
• Margin Compression: Gross margin percentage declined slightly (10.6% in Q3 2007 vs. 11.0% in Q3 2006) due to contract renewals with group purchasing organizations offering favorable pricing for volume.
• Debt Reduction: Long-term debt decreased by approximately $202 million from year-end 2006 to Q3 2007, driven by strong operating cash flows used to pay down the revolving credit facility.
• DTC Segment Turnaround: The Direct-to-Consumer segment reported operating earnings of $1.2 million in Q3 2007, a significant improvement from an operating loss of $4.7 million in Q3 2006.

Guidance, Outlook, and Risks

• Management Commentary: Management highlighted improved asset management, specifically reductions in accounts receivable and inventory levels following the transition of the McKesson business. Days Sales Outstanding (DSO) increased to 29.5 days in Q3 2007 (from 27.0 days in Q3 2006) but improved from the prior quarter. Inventory turnover improved to 9.8.
• Acquisition Adjustments: The company finalized the purchase price allocation for the McKesson acquisition in Q3 2007, resulting in a $12.7 million increase to goodwill and a $16.5 million cash receipt from McKesson related to inventory valuation adjustments.
• Legal Contingency (IRS): The company is in final settlement negotiations with the IRS regarding a proposed disallowance of LIFO inventory valuation reductions. While a potential deficiency of $73.0 million plus interest exists if unsuccessful, management believes the ultimate resolution will not have a material impact on net income, equity, or cash flow.
• Risk Factors: Key risks include dependence on major customers and suppliers, changes in reimbursement guidelines (Medicare/Medicaid), competition, and the ability to manage financing costs. The company maintains $310.7 million in available credit under its revolving facility.

Investor Verification Checklist

• IRS Litigation Outcome: Verify the final terms of the settlement with the IRS regarding the LIFO inventory valuation to confirm the non-materiality assertion.
• McKesson Integration: Monitor the continued performance of the acquired McKesson Acute-Care business, which drives the majority of revenue growth but also impacts working capital metrics (DSO/Inventory).
• Gross Margin Trends: Track gross margin percentages closely, as contract renewals with group purchasing organizations continue to exert downward pressure on margins.
• Liquidity Position: Review cash balances ($3.7 million) relative to the size of operations and the $350 million credit facility capacity to ensure sufficient liquidity for working capital needs.
• DTC Segment Stability: Confirm the sustainability of the DTC segment's turnaround from loss to profitability, specifically regarding allowance for doubtful accounts and reimbursement rates.